Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology
JCI - PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
The Case of a Late Bleeder Plasminogen Activator Inhibitor 1 Deficiency
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles | Physiology
Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance | Cell Death & Disease
PAI1 Monoclonal Antibody (242816) (MA5-23790)
PAI-1: An Integrator of Cell Signaling and Migration
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease | NEJM
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
Overview of the plasminogen activator system. PAI-1, PAI-2, and nexin... | Download Scientific Diagram
PAI-1: An Integrator of Cell Signaling and Migration
Intestinal Research
PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer - ScienceDirect
Plasminogen Activator Inhibitor-1 Signaling Pathway - Creative Diagnostics
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
Pathways involved in the regulation of PAI-1 expression and function in... | Download Scientific Diagram
Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population | PLOS ONE
Anti-PAI1 antibody (ab66705) | Abcam
Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis - Rabieian - 2018 - Journal of Cellular Biochemistry - Wiley Online Library
LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy: Molecular Therapy
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology
Mouse PAI1 ELISA Kit (SERPINE1) (ab197752) | Abcam
Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics
Biomolecules | Free Full-Text | The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
Disease Overview | Rare Coagulation Disorders | Rare Bleeding Disorders
A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage - ScienceDirect
